Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A bone hyperplasia and drug technology, applied in drug combinations, bone diseases, medical formulas, etc., can solve problems such as unsatisfactory treatment methods and easy recurrence of the disease
Inactive Publication Date: 2014-09-24
许宏现
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Practice has proved that these treatment methods are not ideal, and all have limitations. They only treat the symptoms but not the root cause, and the disease is prone to relapse.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0013] Take wild eucommia vine, Haijinsha, Aesculus vine, Aesculus tree, money tree, Jianxuefei, Feilongzhangxue, Shuilanqing, half leaf, Touguxiao, Xueteng, Zoumafeng, Zoumajin 24 kinds of medicinal stems, leaves or roots, such as Sanfangzhao, Yanziwei, Jiulongteng, Xuefengteng, Qianjinli, Qianjindao, Shuangfeidie, Guanzhong, Xiegan, Chuanposhi, Upside-down lotus, etc., take 21 per share Kejia local special rice wine (about 30 degrees) 2000 ml soaked for 96 hours and then take the liquid to make medicine.
[0014] Clinical application
[0015] When applying the present invention to treat hyperosteogeny, the patient can take the prepared medicinal liquid twice in the morning and evening, 21 milliliters each time, and rub the medicinal liquid on the hyperplasia part of the patient, and 12 days is a course of treatment.
[0016] If the patient is already in the late stage of severe bone hyperplasia, in order to improve the curative effect of the medicine, the patient can take t...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicament for treating hyperosteogeny. 21 grams of each of dry stems, leaves or roots of 24 medicinal materials of wild eucommia ulmoides vines, lygodium japonicum, schefflera arboricola vines, schefflera arboricola trees, paliurus hemsleyanus, caesalpinia cucullata, asiatic toddalia roots, ilexmacrocarpa oliv, wilson passionflower herbs, longtube groundIvy herbs, hypoglaucum schizophragma, laciniate blumea herbs, laciniate blumea stems, carex brownii tucker, passiflora henryi hemsl, champion bauhinia stems, smoothfruit ventilago roots and stems, rhizoma smilacis glabrae, moghania philippinensis, tylophora floribunda miq., cyrtomium fortune, blackberry lily, radix et caulis ventilaginis leiocarpae, fuchsia magellanica and the like are added with 2000 ml of local specially-prepared rice wine (with an alcoholic strength of about 30 degrees) and soaked for 96 hours to obtain the liquid which is the medicament. When in use, the prepared medicinal liquid can be orally taken by patients twice in the morning and in the evening, 21 ml for each time, and the medicinal liquid can be applied to hyperplastic parts of the patients with 12 days as a treatment course. For severe patients, the prepared medicinal liquid can be orally taken by patients for third times in the morning, at noon and in the evening, 21 ml for each time, and the medicinal liquid can be applied to hyperplastic parts of the patients to soften, eliminate, and cure the hyperplastic parts. One treatment course takes 12 days. The medicament of the invention has significant treatment effect after clinical practical application; hyperplastic parts of most patients are softened, eliminated and cured after the medicament is taken for 1-3 treatment courses, and no recurrence occurs.
Description
technical field [0001] The invention relates to the treatment of hyperosteogeny, in particular to a medicine for treating hyperosteogeny. Background technique [0002] Osteoarthritis, also known as proliferative osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, and hypertrophic arthritis, is due to the degeneration of soft tissues such as cartilage, intervertebral discs, and ligaments that make up the joints. Degeneration, the formation of bone spurs on the edge of the joint, hypertrophy of the synovium, and other changes, resulting in bone destruction, causing secondary bone hyperplasia, leading to joint deformation, and a disease that causes joint pain and limited mobility when subjected to abnormal loads . Bone hyperplasia is divided into two types: primary and secondary. Traditional Chinese medicine believes that the disease is related to trauma, strain, blood stasis blocking collaterals, feeling wind-cold dampness, internal resistance ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more